CN103859379A - 一种有助于改善记忆的养生保健食品配方及其制备方法 - Google Patents
一种有助于改善记忆的养生保健食品配方及其制备方法 Download PDFInfo
- Publication number
- CN103859379A CN103859379A CN201210532293.9A CN201210532293A CN103859379A CN 103859379 A CN103859379 A CN 103859379A CN 201210532293 A CN201210532293 A CN 201210532293A CN 103859379 A CN103859379 A CN 103859379A
- Authority
- CN
- China
- Prior art keywords
- parts
- formula
- health
- preparation
- contributes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 19
- 230000036541 health Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000004321 preservation Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 20
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 19
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 19
- 235000008397 ginger Nutrition 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 11
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 11
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 10
- 206010016256 fatigue Diseases 0.000 claims abstract description 10
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 240000000249 Morus alba Species 0.000 claims abstract description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims abstract description 7
- 206010022437 insomnia Diseases 0.000 claims abstract description 7
- 208000019901 Anxiety disease Diseases 0.000 claims abstract description 4
- 230000036506 anxiety Effects 0.000 claims abstract description 4
- 208000033065 inborn errors of immunity Diseases 0.000 claims abstract description 3
- 230000006386 memory function Effects 0.000 claims abstract description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 claims abstract description 3
- 244000241872 Lycium chinense Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 241000218231 Moraceae Species 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 206010057315 Daydreaming Diseases 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 1
- 244000241838 Lycium barbarum Species 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 2
- 241000037831 Polygonatum sibiricum Species 0.000 abstract description 2
- 230000006735 deficit Effects 0.000 abstract description 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 29
- 210000000952 spleen Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 20
- 239000003814 drug Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 9
- 238000012549 training Methods 0.000 description 9
- 206010003549 asthenia Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010049865 Achromotrichia acquired Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 244000281702 Dioscorea villosa Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 2
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 2
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000002605 anti-dotal effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000006025 fining agent Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000227129 Aconitum Species 0.000 description 1
- 241000304531 Allium macrostemon Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000035943 Aphagia Diseases 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 101100011511 Mus musculus Elovl6 gene Proteins 0.000 description 1
- 101100246038 Mus musculus Ptpn5 gene Proteins 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241001468611 Polygonatum cyrtonema Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001355 anti-mycobacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 210000000776 antibody secreting cell Anatomy 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 108010002060 leukoregulin Proteins 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001053 orthosympathetic effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O QZZGJDVWLFXDLK-UHFFFAOYSA-N 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供一种有助于改善记忆的养生保健食品配方及其制备方法。它包括下列重量份数比的原料:枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、龙眼肉1400份、大枣1000份、蜂蜜2000份、生姜汁600份、黑芝麻1200份。本发明制备工艺采用传统水煎提取方法,提取物直接分装入袋,工艺简单、服用方便。本发明用于改善记忆功能,减轻精神不振、易疲劳、免疫力低下、失眠、焦虑、注意力不集中等症状。
Description
技术领域
本发明公开了一种有助于改善记忆的养生保健食品配方及其制备方法。
背景技术
随着科技的发展,人们日常生活水平得到显著提高,工作压力也越来越大,很多人出现记忆力下降,临床上尤以40~60岁的知识女性最为多见,她们迫切渴望知识更新,却常常感到力不从心;一些中青年男性,由于社会压力引发心理问题,感到工作紧张、焦虑、易怒,导致记忆力下降;老年群体中的部分知识女性或退休人员,也主诉记忆受损,越是重要的东西越是想不起来。祖国医药中药食同源的中药如黑芝麻、大枣、龙眼肉等均具有增强记忆的作用。
发明内容
本发明的目的是提供一种有助于改善记忆的养生保健食品配方及其制备方法。
本发明是由下述重量份数的原料制成的:枸杞子600-1400份、黄精600-1500份、茯苓600-1500份、山药1000-2000份、桑椹800-1300份、龙眼肉800-2000份、大枣400-1700份、蜂蜜1300-3200份、生姜汁300-1000份、黑芝麻700-1700份。
以上各成分的最佳重量配比是:枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、龙眼肉1400份、大枣1000份、蜂蜜2000份、生姜汁600份、黑芝麻1200份。
一、本发明制备方法包括以下步骤:
(1)将配方中各原料置于煮提锅中,浸润30分钟,然后加入10倍量的去离子水,室温浸泡2小时后加热至沸腾,煮沸提取2小时,倾出水提液,过滤。
(2)再次加入原料10倍量的去离子水,煮沸提取2小时,倾出水提液,过滤。
(3)合并步骤(1)、(2)所得滤液,冷却至室温,离心30分钟,弃去沉淀,收集上清液。
(4)将步骤(3)所得的滤液浓缩至药液比为1∶2(60℃),添加天然吸附澄清剂(北京正天成澄清技术有限公司),离心30分钟,弃去沉淀,收集上清液;
(5)将步骤(4)所得的上清液浓缩至相对密度≥1.27g·ml-1(60℃),干燥,粉碎,分装成10克的小包装。
本发明的配方组成合理,制作工艺科学,携带及食用方便。长期食用本品有助于改善记忆功能,减轻精神不振、易疲劳、免疫力低下、失眠、焦虑、注意力不集中等症状。
二、用药分析
枸杞子为茄科植物宁夏枸杞Lycium barbarum L.的干燥成熟果实。
【性味与归经】甘、平。归肝、肾经。
【功效】滋补肝肾,益精明目。
【应用】治疗精血不足所致的视力减退、内障目昏、头晕目眩、腰膝酸软、遗精滑泄、耳聋、牙齿松动、须发早白、失眠多梦以及肝肾阴虚,潮热盗汗、消渴等证。
《神农本草经》称枸杞子“久服坚筋骨,轻身不老,耐寒暑”。
《本草汇言》赞之“使气可充,血可补,阳可生,阴可长”。
《本草纲目》记载:“枸杞,补肾生精,养肝,明目,坚筋骨,去疲劳,易颜色,变白,明目安神,令人长寿。”
现代医学研究证实:枸杞子含有甜菜硷、多糖、粗脂肪、粗蛋白、胡萝卜素、维生素A、维生素C、维生素B1、维生素B2及钙、磷、铁、锌、锰、亚油酸等营养成分。枸杞子对免疫有促进作用,同时具有免疫调节作用;可提高血睾酮水平,起强壮作用;对造血功能有促进作用;对正常健康人也有显著升白细胞作用;还有抗氧化、抗衰老、抗疲劳、抗突变、抗肿瘤、降血脂、保肝及抗脂肪肝、降血糖、降血压、补肾、明目、养颜、健脑、排毒、保护生殖系统、抗辐射损伤等功能。
黄精为百合科植物滇黄精(Polygonatum kingianum Coll.et Hemsl.)、黄精(Polygonatumsibiricum Red.)或多花黄精(Polygonatum cyrtonema Hua.)的干燥根茎。
【性味与归经】甘、平。归脾、肺、肾经。
【功效】补气养阴,健脾,润肺,益肾。
【应用】治疗肺金气阴两伤之干咳少痰、肺肾阴虚之劳嗽久咳、脾胃虚弱、体倦乏力、食欲不振、口干食少,能延缓衰老,改善头晕、腰膝酸软、须发早白、精血不足,内热消渴等症。
《本草纲目》:“补诸虚、止寒热、填精髓。”
《日华子本草》:“补五劳七伤,助筋骨,生肌,耐寒暑,益脾胃,润心肺”。
现代医学研究证实:黄精根茎含烟酸、粘液质、醌类,并含黄精多糖甲、乙、丙,黄精低聚糖甲、乙、丙,多糖甲、乙、丙均由葡萄糖、甘露糖、半乳糖醛酸结合而成;低聚糖甲、乙、丙均由葡萄糖和果糖结合而成,另含赖氨酸等11种氨基酸。能提高机体免疫功能和促进DNA、RNA及蛋白质的合成,促进淋巴细胞转化作用;具有显著的抗结核杆菌作用;对多种致病性真菌有抑制作用;对伤寒杆菌、金黄色葡萄球菌也有抑制作用;有增加冠脉流量及降压作用,并能降血脂及减轻冠状动脉粥样硬化程度;对肾上腺素引起的血糖过高呈显著抑制作用;还有抑制肾上腺皮质的作用和延缓衰老作用;黄精多糖具有免疫激活作用。
茯苓为多孔菌科真菌茯苓Poria cocos(Schw.)Wolf的干燥菌核。
【性味与归经】甘、淡,平。归心、肺、脾、肾经。
【功效】利水渗湿,健脾宁心。
【应用】用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
《日华子本草》:“补五劳七伤,安胎,暖腰膝,开心益智,止健忘。”
《用药心法》:“茯苓,淡能利窍,甘以助阳,除湿之圣药也。味甘平补阳,益脾逐水,生津导气。”
现代医学研究证实:茯苓能增强机体免疫功能,茯苓多糖具有抗胸腺萎缩及抗脾脏增大和抑制肿瘤生长的功能,茯苓多糖灌胃能增强小鼠巨噬细胞吞噬功能,增加ANAE阳性淋巴细胞数,还能使小鼠脾脏抗体分泌细胞数明显增多。茯苓多糖亦能使环磷酰胺所引起的大白鼠白细胞减少加速回升。羧甲基茯苓多糖还有免疫调节、保肝降酶、间接抗病毒、诱生和促诱生干扰素、减轻放射副反应,诱生和促诱生白细胞调节素等多种生理活性。
山药为薯蓣科植物薯蓣Dioscorea opposite Thumb.的干燥根茎。
【性味与归经】甘,平。归肺、脾、肾经。
【功效】补脾养胃,生津益肺,补肾涩精。
【应用】山药味甘性平,作用缓和,不寒不热,既能补气,又能养阴,补而不滞,滋而不腻。乃平补肺脾肾之佳品。多用于消瘦乏力、食少、便溏者,如《本草纲目》云:“益肾气,健脾胃。”因其含有较多的营养成分,又容易消化吸收,可作为食品长期使用。《神农本草经》云其“补中,益气力,长肌肉”,故对于慢性病或病后虚弱,需营养调补而脾运不健者,则是佳品,如薏米山药粥。
现代医学研究证实:山药的主要成分为淀粉酶,能刺激胃肠道运动,促进肠内物排空,增加小肠吸收功能,有助于消化,降压,降糖,防治心血管疾病。山药的提纯淀粉能降低类脂浓度,同时降低主动脉和心脏的糖的浓度及胆固醇的浓度。山药富含多糖,可刺激和调节免疫系统,能增加血液白细胞含量,加强白细胞的吞噬作用,因此山药可作为人们增加免疫能力的保健药。山药中含有蛋白质(包括人体所需要的16种氨基酸)、糖类、维生素类等有效成分,具有较好的延缓衰老的作用,显著延长生命,经常食用山药,有益健康。
桑椹为桑科植物桑Morus alba L.的干燥果穗。
【性味与归经】甘、酸,寒。归肝、肾经。
【功效】滋阴补血,生津润燥。
【应用】适用于眩晕耳鸣、心悸失眠、须发早白、津伤口渴、内热消渴、血虚便秘、目暗,耳鸣、瘰疬、关节不利。
《滇南本草》:“益肾脏而固精,久服黑发明目。”
《随息隐居食谱》:“滋肝肾,充血液,祛风湿,健步履,息虚风,清虚火。”
《本草拾遗》:“利五脏关节,通血气。久服不饥,安魂镇神,令人聪明,变白不老。”
现代医学研究证实:桑椹含糖、鞣酸、苹果酸及维生素B1、B2,C和胡萝卜素。桑椹油的脂肪酸主要由亚油酸和硬脂酸、油酸等组成。有改善皮肤(包括头皮)血液供应,营养肌肤,使皮肤白嫩及乌发等作用,并能延缓衰老,是健体美颜、抗衰老的佳果与良药。常食桑椹可以明目,缓解眼睛疲劳干涩的症状。桑葚具有免疫促进作用,对脾脏有增重作用,对溶血性反应有增强作用,可防止人体动脉硬化、骨骼关节硬化,促进新陈代谢。它可以促进血红细胞的生长,防止白细胞减少,并对治疗糖尿病、贫血、高血压、高血脂、冠心病、神经衰弱等病症具有辅助功效。适量食用能促进胃液分泌,刺激肠蠕动及解除燥热。
大枣为鼠李科植物枣Ziziphus jujube Mill.的干燥成熟果实。
【性味与归经】甘,温。归脾、胃、心经。
【功效】补中益气,养血安神。
【应用】用于脾虚食少,乏力便溏,妇人脏躁。
《本经》:“主心腹邪气,安中养脾,助十二经。平胃气,通九窍,补少气、少津液,身中不足,大惊,四肢重,和百药。”
《别录》:“补中益气,强力,除烦闷,疗心下悬,肠僻澼。”
《日华子本草》:“润心肺,止嗽。补五脏,治虚劳损,除肠胃癣气。”
《药品化义》:“养血补肝。”
《本草再新》:“补中益气,滋肾暖胃,治阴虚。”
现代医学研究证实:大枣中含有多种生物活性物质,如大枣多糖、黄酮类、皂苷类、三萜类、生物碱类、环磷酸腺苷(cAMP)、环磷酸乌苷(cGMP)等,对人体有多种保健治病功效。如抗肿瘤、抗氧化、降血压、降胆固醇、保肝护肝、增强免疫力等保健功能。
龙眼肉为无患子科植物龙眼Dimocarpus longan Lour.的假种皮。
【性味与归经】甘,温。归心、脾经。
【功效】补益心脾,养血安神。
【应用】用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。
《得配本草》:“益脾胃,葆心血,润五脏,治怔忡。”
《日用本草》:“益智宁心。”
现代医学研究证实:龙眼鲜食,味甜美爽口,且营养价值甚高,富含高碳水化合物、蛋白质、多种氨基酸和维生素B、C、钙、磷、铁、酒石酸、腺膘呤等,其中尤以含维生素P量多,对中老年人而言,有保护血管、防止血管硬化和脆性的作用。对与衰老过程有密切关系的黄素蛋白-脑B型单胺氧化酶(MAO-B)有较强的抑制作用。因含铁及维生素B2很丰富,可以减轻子宫收缩及宫体下垂感。
蜂蜜为蜜蜂科昆虫中华蜜蜂Apis cerana Fabricius或意大利蜂Apis mellifera Linnaeus所酿的蜜。
【性味与归经】甘,平。归肺、脾、大肠经。
【功效】补中,润燥,止痛,解毒;外用生肌敛疮。
【应用】用于脘腹虚痛,肺燥干咳,肠燥便秘,解乌头类药毒;外治疮疡不敛,水火烫伤。
《本经》:主心腹邪气,诸惊痫,安五脏诸不足,益气补中,止痛解毒,和百药。
《名医别录》:养脾气,除心烦,食饮不下,肌中疼痛,口疮,明耳目。
《本草拾遗》:主牙齿疳疮,目肤赤障,杀虫。
《本草衍义》:汤火伤涂之痛止,仍捣薤白相和。
《纲目》:和营卫、润脏腑,通三焦,调脾胃。
现代医学研究证实:蜂蜜能改善血液的成份,促进心脑和血管功能蜂蜜对肝脏有保护作用,能促使肝细胞再生,对脂肪肝的形成有一定的抑制作用。食用蜂蜜能迅速补充体力,消除疲劳,增强对疾病的抵抗力。蜂蜜还有杀菌,抗氧化,抗癌,防衰老的作用。
生姜汁为姜科植物姜Zingiber officinale Rosc.的新鲜根茎汁。
【性味与归经】味辛、性温,入肺、胃、脾经。
【功效】解表散寒,温中止呕,化痰止咳,解鱼蟹毒。
【应用】用于风寒感冒,胃寒呕吐,寒痰咳嗽,鱼蟹中毒。
《食疗本草》说它“止逆,散烦闷,开胃气”。《本草拾遗》记载生姜“汁解毒药,破血调中,去冷除痰,开胃”。《本草从新》指出“姜汁,开痰,治噎膈反胃”。
现代医学研究证实:生姜具有解毒杀菌的作用,所以日常人们在吃松花蛋或鱼蟹等水产时,通常会放上一些姜末、姜汁。生姜中的姜辣素能抗衰老,老年人常吃生姜可除“老年斑”。生姜的提取物能刺激胃粘膜,引起血管运动中枢及交感神经的反射性兴奋,促进血液循环,振奋胃功能,达到健胃、止痛、发汗、解热的作用。姜的挥发油能增强胃液的分泌和肠壁的蠕动,从而帮助消化。生姜中分离出来的姜烯、姜酮的混合物有明显的止呕吐作用。生姜还有抑制癌细胞活性的作用。
黑芝麻为脂麻科植物脂麻Sesamum indicum L.的干燥成熟种子。
【性味与归经】甘,平。归肝、肾、大肠经。
【功效】补肝肾,益精血,润肠燥。
【应用】用于精血亏虚,头暈眼花,耳鸣耳聋,须发早白,病后脱发,肠燥便秘。
现代医学研究证实:黑芝麻种子含脂肪油可达60%,油中含油酸、亚油酸、棕榈酸、花生酸、廿四酸、廿二酸等的甘油酯,亦含甾醇、芝麻素(Sesamin)、芝麻酚(Sesamol)、芝麻林素(Sesamolin)、维生素E等。芝麻素具有抗病毒、杀菌、抗氧化、杀虫增效、治疗气管炎等作用。
三、功能学评价
发明产品改善记忆力的试验研究
【试验动物】
昆明种雄性小鼠,6~8周龄、体重18~22g。
【试验方法】
1、分组及给药剂量
取昆明种小鼠40只,随机分为4组,每组10只,设置阴性对照组、发明产品低、中、高剂量组(分别为人群推荐量的5、10、20倍,即2.5g/kg、5g/kg、10g/kg),连续灌胃给予发明产品30d,阴性对照组给予等体积蒸馏水,小鼠的灌胃剂量为0.2mL/10g。
2、跳台试验
选小鼠40只,分组及给药剂量同上,连续给药30d。将动物放入反应箱内适应3min,立即通以36伏交流电,动物的正常反应是跳回到绝缘平台上。多数动物可能再次或多次跳至铜栅上,受到电击又迅速跳回平台。训练一次后,将动物放在反应箱内的平台上,记录5min内每鼠受到电击的次数(错误次数),以此作为学习成绩。24h后重测验,记录受电击的动物数、第一次跳下平台的潜伏期和3min内的错误次数。
3、避暗试验
动物选择,试验分组,给药的剂量、途径、时间均同跳台试验,连续给药30d后开始进行避暗训练。实验时将小鼠面部背向洞口放入明室,同时启动计时器,动物穿过洞口进入暗室受到电击,计时器停止,取出小鼠,记录每鼠从放入明室至进入暗室内遭电击所需的时间,即潜伏期。24h后同一时间,进行重复测验,记录每鼠进入暗室的潜伏期、5min内的错误次数和进入暗室的动物数。
4、水迷宫试验
动物选择,试验分组,给药的剂量、途径、时间均同跳台试验。连续给药30d后开始进行水迷宫试验,训练期间继续给药,每天训练1次,连续5d,第1d训练前将小鼠放在梯子附近,使其自动爬上3次,以后每次训练前将小鼠放在梯子附近,使其自动爬上1次。第1d训练时,用挡板在A处挡住,进行训练。第2d从B处开始,此路程训练3次,80%的动物到期达终点。第5d从起点S开始训练,最后以5d的总学习成绩进行评价(即各组2分钟内到达终点的动物数、每组5d平均错误次数和到达终点的时间)。
【试验结果】
1、跳台试验
由表1可见,经口给予小鼠不同剂量的发明产品30d,记忆获得(训练)过程中,低、中、高剂量组测验潜伏期时间均有所延长,且高剂量组与对照组比较,差异有显著性(P<0.05);高剂量组的平均错误次数少于对照组,差异有显著性(P<0.05);错误反应率低于对照组,差异亦有显著性(P<0.05)。
注:与阴性对照组比较,*P<0.05。
2、避暗试验
表2结果可见,给予小鼠不同剂量的发明产品30d,高剂量组的平均潜伏期长于对照组,差异有显著性(P<0.05);中、高剂量组的错误反应率低于对照组,差异亦有统计学意义(P<0.05,P<0.01)。
注:与阴性对照组比较,*P<0.05,**P<0.01。
3、水迷宫试验
由表3结果可见,给予小鼠不同剂量的发明产品30d,与对照组比较,各剂量组动物到达终点所需的时间明显缩短;平均错误次数明显减少;到达终点的动物数明显高于对照组。与对照组比,三个剂量组动物到达终点时间差异均有显著性(P<0.05);高剂量组动物错误次数也有显著性差异(P<0.05);中、高剂量组到达终点的动物数有显著性和极显著性差异(P<0.05,P<0.01)。
注:与阴性对照组比较,*P<0.05,**P<0.01。
【试验结论】
通过以上试验结果证实本发明产品有改善记忆的功能。
具体实施方式
实施例1提取物及产品的制备
按最佳重量配比称取枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、龙眼肉1400份、大枣1000份、蜂蜜2000份、生姜汁600份、黑芝麻1200份。加10倍量去离子水煮提2次,每次2小时,煮提液过滤、离心(3000转/分)30分钟,取上清液,浓缩至药液比1∶2(60℃),后加入天然吸附澄清剂(4%澄清剂A,8%澄清剂B),然后离心(3000转/分)30分钟,取上清液继续浓缩至相对密度≥1.27g·ml-1(60℃)后,带式干燥,粉碎成细粉,分装成10克左右的小包装。
实施例2产品辅助治疗记忆力下降
个案报道
赵××,女,53岁,某办公室主任。自述有精神不振、易疲劳、健忘等症状,服食本品每日2袋,连续30天后,感觉记忆力有所恢复,免疫力增强,不再容易疲劳,精神状态也得到改善。
Claims (4)
1.一种有助于改善记忆的养生保健食品配方,其特征在于所用的原料及其重量份数:枸杞子600-1400份、黄精600-1500份、茯苓600-1500份、山药1000-2000份、桑椹800-1300份、龙眼肉800-2000份、大枣400-1700份、蜂蜜1300-3200份、生姜汁300-1000份、黑芝麻700-1700份。
2.根据权利要求1所述的一种有助于改善记忆的养生保健食品配方,其特征在于所用的原料及其最佳重量配比:枸杞子1000份、黄精1000份、茯苓1000份、山药1500份、桑葚1000份、龙眼肉1400份、大枣1000份、蜂蜜2000份、生姜汁600份、黑芝麻1200份。
3.根据权利要求1或2所述的一种有助于改善记忆的养生保健食品配方及其制备方法,其特征在于制备过程按以下步骤进行:
(1)将配方中各原料置于煮提锅中,浸润30分钟,然后加入10倍量的去离子水,室温浸泡2小时;然后加热至沸腾,煮沸提取2小时,倾出水提液,过滤;
(2)再次加入原料10倍量的去离子水,煮沸提取2小时,倾出水提液,过滤;
(3)合并步骤(1)、(2)所得滤液,冷却,离心,弃去沉淀,收集上清液;
(4)将步骤(3)所得的滤液浓缩,添加天然吸附澄清剂,弃去沉淀,收集上清液;
(5)将步骤(4)所得的上清液浓缩,干燥,粉碎,分装成10克的小包装。
4.根据权利要求1或2所述的一种有助于改善记忆的养生保健食品配方,其特征在于:本发明用于改善记忆功能,减轻精神不振、易疲劳、免疫力低下、失眠、焦虑、注意力不集中等症状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210532293.9A CN103859379A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于改善记忆的养生保健食品配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210532293.9A CN103859379A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于改善记忆的养生保健食品配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103859379A true CN103859379A (zh) | 2014-06-18 |
Family
ID=50898837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210532293.9A Pending CN103859379A (zh) | 2012-12-10 | 2012-12-10 | 一种有助于改善记忆的养生保健食品配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103859379A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456627A (zh) * | 2015-12-25 | 2016-04-06 | 梁燕妮 | 治疗失眠的中药丸及其制备方法 |
CN105456628A (zh) * | 2015-12-25 | 2016-04-06 | 梁燕妮 | 防治失眠的米酒及其制备方法 |
CN106071517A (zh) * | 2016-06-02 | 2016-11-09 | 王成亚 | 温胃滋阳的健康饮料 |
CN109620914A (zh) * | 2019-01-11 | 2019-04-16 | 江苏康缘药业股份有限公司 | 一种调理亚健康的中药组合物及其制备方法和应用 |
CN109731080A (zh) * | 2019-03-22 | 2019-05-10 | 厦门元之道生物科技有限公司 | 一种中药发酵剂及其制备方法 |
CN110624048A (zh) * | 2019-11-01 | 2019-12-31 | 广西中医药大学 | 黄精桑椹饮在制备增强免疫力组合物方面的用途 |
CN110710686A (zh) * | 2019-10-31 | 2020-01-21 | 北京同仁堂健康药业(青海)有限公司 | 一种缓解疲劳的口服液及其制备方法 |
CN110903935A (zh) * | 2019-11-28 | 2020-03-24 | 广东心宝药业科技有限公司 | 一种安神养生饮品及其制备方法 |
CN113908251A (zh) * | 2021-12-13 | 2022-01-11 | 广东益可维生物技术有限公司 | 提高免疫力的中药组合物、中药发酵酸奶及其制备方法 |
CN114098085A (zh) * | 2021-12-06 | 2022-03-01 | 中国医科大学 | 一种具有辅助改善记忆功能的功能性食品组合物及用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1224056A (zh) * | 1998-01-19 | 1999-07-28 | 王维 | 智能补脑酒 |
CN102188658A (zh) * | 2011-04-21 | 2011-09-21 | 北京身心康国际中医研究院 | 用于阴虚体质人缓解精血亏虚中药制剂及其制备方法及应用 |
CN102198220A (zh) * | 2010-03-26 | 2011-09-28 | 王忠民 | 一种抗疲劳与增强记忆力的药物 |
CN102511871A (zh) * | 2011-12-29 | 2012-06-27 | 山西汉波食品股份有限公司 | 补肾强身红枣浓浆 |
CN102783687A (zh) * | 2012-07-24 | 2012-11-21 | 马千里 | 一种具有增强记忆力作用的饮料及其制备方法 |
-
2012
- 2012-12-10 CN CN201210532293.9A patent/CN103859379A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1224056A (zh) * | 1998-01-19 | 1999-07-28 | 王维 | 智能补脑酒 |
CN102198220A (zh) * | 2010-03-26 | 2011-09-28 | 王忠民 | 一种抗疲劳与增强记忆力的药物 |
CN102188658A (zh) * | 2011-04-21 | 2011-09-21 | 北京身心康国际中医研究院 | 用于阴虚体质人缓解精血亏虚中药制剂及其制备方法及应用 |
CN102511871A (zh) * | 2011-12-29 | 2012-06-27 | 山西汉波食品股份有限公司 | 补肾强身红枣浓浆 |
CN102783687A (zh) * | 2012-07-24 | 2012-11-21 | 马千里 | 一种具有增强记忆力作用的饮料及其制备方法 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105456627A (zh) * | 2015-12-25 | 2016-04-06 | 梁燕妮 | 治疗失眠的中药丸及其制备方法 |
CN105456628A (zh) * | 2015-12-25 | 2016-04-06 | 梁燕妮 | 防治失眠的米酒及其制备方法 |
CN106071517A (zh) * | 2016-06-02 | 2016-11-09 | 王成亚 | 温胃滋阳的健康饮料 |
CN109620914A (zh) * | 2019-01-11 | 2019-04-16 | 江苏康缘药业股份有限公司 | 一种调理亚健康的中药组合物及其制备方法和应用 |
CN109731080A (zh) * | 2019-03-22 | 2019-05-10 | 厦门元之道生物科技有限公司 | 一种中药发酵剂及其制备方法 |
CN109731080B (zh) * | 2019-03-22 | 2021-09-24 | 厦门元之道生物科技有限公司 | 一种中药发酵剂及其制备方法 |
CN110710686A (zh) * | 2019-10-31 | 2020-01-21 | 北京同仁堂健康药业(青海)有限公司 | 一种缓解疲劳的口服液及其制备方法 |
CN110624048A (zh) * | 2019-11-01 | 2019-12-31 | 广西中医药大学 | 黄精桑椹饮在制备增强免疫力组合物方面的用途 |
CN110903935A (zh) * | 2019-11-28 | 2020-03-24 | 广东心宝药业科技有限公司 | 一种安神养生饮品及其制备方法 |
CN114098085A (zh) * | 2021-12-06 | 2022-03-01 | 中国医科大学 | 一种具有辅助改善记忆功能的功能性食品组合物及用途 |
CN114098085B (zh) * | 2021-12-06 | 2023-05-12 | 中国医科大学 | 一种具有辅助改善记忆功能的功能性食品组合物及用途 |
CN113908251A (zh) * | 2021-12-13 | 2022-01-11 | 广东益可维生物技术有限公司 | 提高免疫力的中药组合物、中药发酵酸奶及其制备方法 |
CN113908251B (zh) * | 2021-12-13 | 2022-03-25 | 广东益可维生物技术有限公司 | 提高免疫力的中药组合物、中药发酵酸奶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103859379A (zh) | 一种有助于改善记忆的养生保健食品配方及其制备方法 | |
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN102986887A (zh) | 一种养生风味奶昔及其制备方法 | |
CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
CN103859378A (zh) | 一种有助于降低血糖的养生保健食品配方及其制备方法 | |
CN103859375A (zh) | 一种有助于增强免疫力的养生保健食品配方及其制备方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN103749821B (zh) | 一种提高免疫力的绞股蓝保健茶及其制备方法 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN104109609A (zh) | 糯米酒荞麦果汁饮料及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN103689562A (zh) | 一种有助于缓解疲劳的养生保健食品配方及其制备方法 | |
KR20140137155A (ko) | 원적외선수가 포함되는 발효 흑한방약재 제조방법 | |
CN103859374A (zh) | 一种有助于缓解视疲劳的养生保健食品配方及其制备方法 | |
CN105558838A (zh) | 一种多味黑豆及其制备方法 | |
CN104366349A (zh) | 脆枣松子营养粥及制作方法 | |
CN103689558A (zh) | 一种具有多种功能的养生保健食品配方及其制备方法 | |
CN104397282A (zh) | 一种安神补脑的刺五加保健茶及其制备方法 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN104256821B (zh) | 一种玛咖复方口服液及其制备方法 | |
CN103845628B (zh) | 一种用于治疗猫破伤风的药物及其制备方法 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN107050311A (zh) | 一种治疗脑梗塞、心肌梗塞的药物 | |
CN105582334A (zh) | 全植物保健品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140618 |